Life AI Net
Home
Archive
Calculators
Directory
Newsletter
Login
English
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Home
Archive
Calculators
Directory
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Login
Home
Archive
Calculators
Directory
More
Live
Science
Wolves are reconquering Europe. Can people learn to live with them?
Clinical OMICs
Pakistan’s Massive Genetic Database Reveals Millions of Unique Variants
Clinical OMICs
First Novel Antifungal for Aspergillus in 20 Years Succeeds in Phase III
BioWorld
Money raised by biopharma
BioWorld
Biopharma money raised: Jan. 1-June 18, 2026
Endpoints News
Treasury weighs screening investments in China biotech
BioPharma Dive
cAMPfield lands $180M to build gut disease drug
Endpoints News
Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50M
BioPharma Dive
Biogen adds more immune drugs in $1B buyout of secretive startup Raythera
Promega Blog
What Happens When You Delay an Ebola Vaccine Booster by 18 Months?
FierceBiotech
cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara
Endpoints News
IRA's Medicare out-of-pocket cap increased access to drugs, study finds
Science
Wolves are reconquering Europe. Can people learn to live with them?
Clinical OMICs
Pakistan’s Massive Genetic Database Reveals Millions of Unique Variants
Clinical OMICs
First Novel Antifungal for Aspergillus in 20 Years Succeeds in Phase III
BioWorld
Money raised by biopharma
BioWorld
Biopharma money raised: Jan. 1-June 18, 2026
Endpoints News
Treasury weighs screening investments in China biotech
BioPharma Dive
cAMPfield lands $180M to build gut disease drug
Endpoints News
Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50M
BioPharma Dive
Biogen adds more immune drugs in $1B buyout of secretive startup Raythera
Promega Blog
What Happens When You Delay an Ebola Vaccine Booster by 18 Months?
FierceBiotech
cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara
Endpoints News
IRA's Medicare out-of-pocket cap increased access to drugs, study finds
Archive
This story is not available in the archive.